These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 31176632

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa Capsules.
    Modi NB, Mittur A, Rubens R, Khanna S, Gupta S.
    Clin Neuropharmacol; 2019; 42(1):4-8. PubMed ID: 30520758
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease.
    Verhagen Metman L, Stover N, Chen C, Cowles VE, Sweeney M.
    Mov Disord; 2015 Aug; 30(9):1222-8. PubMed ID: 25847690
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
    Hinson VK, Goetz CG, Leurgans S, Fan W, Nguyen T, Hsu A.
    Clin Neuropharmacol; 2009 Aug; 32(4):189-92. PubMed ID: 19620848
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of levodopa/carbidopa delivered from gastric-retentive extended-release formulations in patients with Parkinson's disease.
    Chen C, Cowles VE, Sweeney M, Stolyarov ID, Illarioshkin SN.
    J Clin Pharmacol; 2012 Jul; 52(7):1069-77. PubMed ID: 21610205
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa.
    Mittur A, Gupta S, Modi NB.
    Clin Pharmacokinet; 2017 Sep; 56(9):999-1014. PubMed ID: 28236251
    [Abstract] [Full Text] [Related]

  • 15. Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease.
    Kestenbaum M, Fahn S.
    Expert Opin Drug Saf; 2015 May; 14(5):761-7. PubMed ID: 25697185
    [Abstract] [Full Text] [Related]

  • 16. Comparison of 200 mg retarded release levodopa/carbidopa - with 150 mg levodopa/carbidopa/entacapone application: pharmacokinetics and efficacy in patients with Parkinson's disease.
    Müller T, Ander L, Kolf K, Woitalla D, Muhlack S.
    J Neural Transm (Vienna); 2007 May; 114(11):1457-62. PubMed ID: 17564755
    [Abstract] [Full Text] [Related]

  • 17. Continuous versus intermittent oral administration of levodopa in Parkinson's disease patients with motor fluctuations: A pharmacokinetics, safety, and efficacy study.
    Warren Olanow C, Torti M, Kieburtz K, Leinonen M, Vacca L, Grassini P, Heller A, Heller E, Stocchi F.
    Mov Disord; 2019 Mar; 34(3):425-429. PubMed ID: 30653246
    [Abstract] [Full Text] [Related]

  • 18. Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa.
    Othman AA, Rosebraugh M, Chatamra K, Locke C, Dutta S.
    J Parkinsons Dis; 2017 Mar; 7(2):275-278. PubMed ID: 28211816
    [Abstract] [Full Text] [Related]

  • 19. Carbidopa/Levodopa ER Capsules (Rytary(®), Numient™): A Review in Parkinson's Disease.
    Greig SL, McKeage K.
    CNS Drugs; 2016 Jan; 30(1):79-90. PubMed ID: 26692288
    [Abstract] [Full Text] [Related]

  • 20. The Accordion Pill®: unique oral delivery to enhance pharmacokinetics and therapeutic benefit of challenging drugs.
    Navon N.
    Ther Deliv; 2019 Jul; 10(7):433-442. PubMed ID: 31203723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.